Your Location：
Home >
Browse articles >
Mechanisms and Clinical Application of Common Oral Chinese Patent Medicines Against Non-small Cell Lung Cancer： A Review
Updated：2023-08-07
Previous|Next

    • Mechanisms and Clinical Application of Common Oral Chinese Patent Medicines Against Non-small Cell Lung Cancer： A Review

    • WEN Yanping , XIAO Haiwei , SHEN Liping , YANG Xiaofeng , YIN Juhua , LIU Lingshuang
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 17, Pages: 260-266(2023)

    • DOI： 10.13422/j.cnki.syfjx.202202027     

      CLC：

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • References

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

483

Views

524

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Clinical Application and Mechanism of Sanrentang Based on Treating Different Diseases with Same Therapy： A Review
Didangtang： A Review
Huangqintang in Treatment of Ulcerative Colitis： A Review
Xiaoyaosan in Treatment of Depression： A Review
Effect of Huposan Against Endometriosis： A Review

Related Author

DOU Xin
PAN Haidi
HE Changhui
WEN Xiaoqing
MEI Xiao
MA Yuanxin
DENG Hualiang
WANG Wei

Related Institution

The First Clinical Medical College， Shandong University of Traditional Chinese Medicine（TCM）
College of TCM，Shandong University of TCM
The Affiliated Hospital of Shandong University of TCM
Liaoning University of Traditional Chinese Medicine（TCM）
The First Affiliated Hospital of Liaoning University of TCM